CAPTRUST Financial Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,867
Closed -$148K 2334
2022
Q4
$148K Sell
13,867
-689
-5% -$8.01K ﹤0.01% 1999
2022
Q3
$152K Buy
14,556
+4,220
+41% +$55K ﹤0.01% 1871
2022
Q2
$130K Buy
10,336
+9,486
+1,116% +$101K ﹤0.01% 2015
2022
Q1
$9K Buy
850
+35
+4% +$425 ﹤0.01% 3848
2021
Q4
$11K Hold
815
﹤0.01% 3652
2021
Q3
$16K Buy
815
+599
+277% +$7.96K ﹤0.01% 3303
2021
Q2
$2K Hold
216
﹤0.01% 4158
2021
Q1
$2K Buy
+216
New +$1.78K ﹤0.01% 4028

Other funds holding DVAX

CAPTRUST Financial Advisors's DVAX Position: Q1 2023 in Review

CAPTRUST Financial Advisors sold out of Dynavax Technologies (DVAX) in Q1 2023, closing a stake of 13,867 shares — an estimated $148K sold.

CAPTRUST Financial Advisors first reported a position in DVAX in Q1 2021 and held it in 8 quarters. The position peaked at $152K in Q3 2022. 216 funds tracked by Wall St. Rank hold DVAX as of Q1 2023.

  • CAPTRUST Financial Advisors reported no remaining Dynavax Technologies position as of Q1 2023 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 13,867 Dynavax Technologies shares in Q1 2023, an estimated $148K.
  • CAPTRUST Financial Advisors first reported a position in Dynavax Technologies in Q1 2021 and held it in 8 quarters.
  • CAPTRUST Financial Advisors's Dynavax Technologies position peaked at $152K in Q3 2022.
  • 216 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2023.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2023, filed 15 May 2023.